Author:
Badar Faraz,Azeez Hayder,Abdulrahman Zeinab,Ashraf Aqsa,Iftikhar Asma
Reference19 articles.
1. A long-term study of young patients with essential thrombocythemia treated with anagrelide;Mazzucconi MG;Haematologica,2004
2. Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3',5'-adenosine monophosphate phosphodiesterase;Tang SS;J Lab Clin Med,1980
3. Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans;Mazur EM;Blood,1992
4. Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia;Tomer A;Blood,2002
5. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile;Steurer M;Cancer,2004